Employer Insights

To reflect your program’s full value, pharmacy needs a clear, intentional spotlight—not a footnote—during Open Enrollment, backed by real, timely support.

Infusion drugs are among the fastest-growing cost drivers for self-funded employers, yet many are leaving significant savings on the table. Are you?

Discover why breaking up with the traditional model could be a smart move for your bottom line and your employees.

Recent FDA changes impact GLP-1 compounding, affecting employer benefits and employee access to weight-loss medications. Employers must evaluate coverage strategies and weight-loss platforms for long-term cost and health outcomes.

We’ll break down key trends in the upcoming pipeline and provide actionable insights on how to navigate the changing landscape.

Health professionals who treat patients with diabetes report three advantages of continuous glucose monitoring when compared to a traditional glucose meter.

Read to learn how employers can strategically manage their formulary strategy to reduce costs and put employees first.

Health care spending is projected to rise 8% in 2025, driven by increased use of GLP-1 drugs for diabetes and obesity.

Patient-centered diabetes program drives significant A1C reduction in just 6 months.

An Educational Resource from True Rx Health Strategists